BTT-3033
BTT-3033 is a potent and orally bioavailable α2β1 integrin inhibitor (EC50: 130 nM) that blocks platelet adhesion and cell proliferation. It has been shown to induce apoptosis and is utilized in research models for prostate cancer, inflammatory conditions, and cardiovascular diseases.
Product Specifications
CAS Number
1259028-99-3
Product Name Alternative
Apoptosis, BTT3033, BTT-3033, BTT 3033, α2β1 integrin
Field of Research
Cell Biology, Signal Transduction
Purity
98.91% (May vary between batches)
Solubility
DMSO:140 mg/mL (300.75 mM)
Smiles
CN (c1ccc (NC (=O) Nc2ccccc2) cc1) S (=O) (=O) c1cnn (c1) -c1ccc (F) cc1
Molecular Formula
C23H20FN5O3S
Molecular Weight
465.5
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx303813-01 20 µg
Family With Sequence Similarity 168, Member B (FAM168B) Antibody (FITC)
Sign In for Pricing
View Details abx303813-02 50 µg
Family With Sequence Similarity 168, Member B (FAM168B) Antibody (FITC)
Sign In for Pricing
View Details abx303813-03 100 µg
Family With Sequence Similarity 168, Member B (FAM168B) Antibody (FITC)
Sign In for Pricing
View Details abx303813-04 200 µg
Family With Sequence Similarity 168, Member B (FAM168B) Antibody (FITC)
Sign In for Pricing
View Details abx303813-05 1 mg
Family With Sequence Similarity 168, Member B (FAM168B) Antibody (FITC)
Sign In for Pricing
View Details 
bs-7610R-BF488 100 µL
ETHE1 Polyclonal Antibody, AbBy Fluor™ 488 Conjugated
Sign In for Pricing
View Details